Hamish Cameron - Venture Partner

Focus: Biotechnology

Summary:
Dr Hamish Cameron joined SVLS in 2008 as a Venture Partner.

Prior Experience:
Before joining SVLS, Dr Cameron was CEO of Cambridge Antibody Technology (“CAT”). Prior to that, he held a series of senior R&D positions at AstraZeneca/Zeneca including Head of the Cardiovascular Therapy Area, Senior Vice-President Medical Research and was a member of the R&D Leadership Team. Dr Cameron started his industry career with Janssen, after working in clinical practice and research in the UK.

Qualifications:
Hamish was trained as a physician and holds MBBS and BSc (Hons) Pharmacology degrees from the University of London. He is a member of the UK Royal College of Physicians and a Fellow and past Board member of the Faculty of Pharmaceutical Medicine.